Detalhe da pesquisa
1.
Long-term outcomes and prognostic factors of patients with lung metastases from differentiated thyroid cancer after radioiodine therapy in Japan.
Endocr J
; 70(3): 315-322, 2023 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36567077
2.
Iodine-131 metaiodobenzylguanidine therapy for neuroblastoma: reports so far and future perspective.
ScientificWorldJournal
; 2015: 189135, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25874239
3.
Effects and safety of ¹³¹I-metaiodobenzylguanidine (MIBG) radiotherapy in malignant neuroendocrine tumors: results from a multicenter observational registry.
Endocr J
; 61(12): 1171-80, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25214026
4.
Radiation exposure lymphocyte damage assessed by γ-H2AX level using flow cytometry.
Sci Rep
; 14(1): 4339, 2024 02 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38383619
5.
Prototype imaging protocols for monitoring the efficacy of iodine-131 ablation in differentiated thyroid cancer.
Hell J Nucl Med
; 16(3): 175-80, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24137580
6.
Recent Advances in Radiopharmaceutical Theranostics of Pheochromocytoma and Paraganglioma.
Semin Nucl Med
; 53(4): 503-516, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36641337
7.
I-131 metaiodobenzylguanidine therapy is a significant treatment option for pheochromocytoma and paraganglioma.
Nuklearmedizin
; 61(3): 231-239, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35668668
8.
Application of a tungsten apron for occupational radiation exposure in nursing care of children with neuroblastoma during 131I-meta-iodo-benzyl-guanidine therapy.
Sci Rep
; 12(1): 47, 2022 01 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34996922
9.
Prognostic factors for refractory pheochromocytoma and paraganglioma after 131I-metaiodobenzylguanidine therapy.
Ann Nucl Med
; 36(1): 61-69, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34647244
10.
An open-label, single-arm, multi-center, phase II clinical trial of single-dose [131I]meta-iodobenzylguanidine therapy for patients with refractory pheochromocytoma and paraganglioma.
Ann Nucl Med
; 36(3): 267-278, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34870794
11.
Randomized placebo-controlled double-blind phase II study of zaltoprofen for patients with diffuse-type and unresectable localized tenosynovial giant cell tumors: The REALIZE study.
Front Oncol
; 12: 900010, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36212437
12.
[Radiation Protection Against Exposure from Patients Receiving 131I-MIBG and Released from Radiation Treatment Room].
Kaku Igaku
; 58(1): 59-66, 2021.
Artigo
em Japonês
| MEDLINE | ID: mdl-34321380
13.
Comparison of the detecting capability between 123I-mIBG and post-therapeutic 131I-mIBG scintigraphy for curie scoring in patients with neuroblastoma after chemotherapy.
Ann Nucl Med
; 35(6): 649-661, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33866530
14.
Radiation exposure in nurses during care of 131I-MIBG therapy for pediatric patients with high-risk neuroblastoma.
Ann Nucl Med
; 34(6): 441-447, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32297135
15.
[The Nationwide Survey on Avoidance of Targeted Radionuclide Therapy in Patients with Limited Activities of Daily Living and Those Undergoing Hemodialysis].
Kaku Igaku
; 57(1): 39-46, 2020.
Artigo
em Japonês
| MEDLINE | ID: mdl-32493847
16.
Diagnostic Use of Post-therapy 131I-Meta-Iodobenzylguanidine Scintigraphy in Consolidation Therapy for Children with High-Risk Neuroblastoma.
Diagnostics (Basel)
; 10(9)2020 Sep 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32887257
17.
High-dose 131I-metaiodobenzylguanidine therapy in patients with high-risk neuroblastoma in Japan.
Ann Nucl Med
; 34(6): 397-406, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32219730
18.
High-dose 131I-mIBG as consolidation therapy in pediatric patients with relapsed neuroblastoma and ganglioneuroblastoma: the Japanese experience.
Ann Nucl Med
; 34(11): 840-846, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32862362
19.
Gated myocardial perfusion SPECT for preoperative risk stratification in patients with noncardiac vascular disease.
Ann Nucl Med
; 23(2): 173-81, 2009 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19225941
20.
Nuclear medicine practice in Japan: a report of the eighth nationwide survey in 2017.
Ann Nucl Med
; 33(10): 725-732, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31236776